Global Hip Dysplasia Registry Reaches 10,000 Patient Milestone!

The Global Hip Dysplasia Registry (GHDR) has officially reached a major milestone, over 10,000 patients recruited from across participating sites worldwide. The registry, the largest of its kind focused on developmental dysplasia of the hip (DDH), represents a collaborative, international effort to gather real-world data to improve outcomes for children diagnosed with DDH.

Since its inception, GHDR has aimed to understand treatment variation, standardize best practices, and track long-term outcomes in DDH care. With 30 centres across 5 continents, this milestone marks a new chapter in what the registry can offer the clinical and research communities.

"Reaching 10,000 patients means we now have one of the most comprehensive global datasets for DDH," said Dr. Emily Schaeffer, lead investigator of the GHDR. "With this level of participation, we can begin addressing key questions around early diagnosis, treatment decision-making, and what outcomes truly matter to patients and families. It's an exciting step forward for the field."

The GHDR team extends deep gratitude to all the patients, families, and clinical sites who contributed to this achievement—and looks forward to translating this data into meaningful change.